1-3 of 3
Xiao-hui Hu
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Venetoclax and decitabine vs intensive chemotherapy as induction for young patients with newly diagnosed AML

Free
Clinical Trials & Observations
Jing Lu, Sheng-li Xue, Ying Wang, Xue-feng He, Xiao-hui Hu, Miao Miao, Yang Zhang, Zai-xiang Tang, Jun-dan Xie, Xiao-fei Yang, Ming-zhu Xu, Yao-yao Shen, Feng Du, Qian Wu, Meng-xing Xue, Yun Wang, Ai-ling Deng, Xue-qing Dou, Yang Xu, Hai-ping Dai, De-pei Wu, Su-ning Chen
Journal: Blood
Blood (2025) 145 (22): 2645–2655.
https://doi.org/10.1182/blood.2024027217
Published: 2025
Includes: Supplemental data
Journal Articles

Venetoclax Combined with Azacitidine Was Effective and Safe for Relapsed/Refractory T-Cell Acute Lymphoblastic Leukemia/ Lymphoblastic Lymphoma: Preliminary Results of a Phase 2, Multicenter Trial

Free
Han-Yu Cao, Lu-Lu Chen, Chao-Ling Wan, Xiao-Hui Hu, Bing Wu, Li Yang, Li Wang, Yang Zhang, De-Pei Wu, Hai-Ping Dai, Hao Zhang, Shengli Xue
Journal: Blood
Blood (2023) 142 (Supplement 1): 1501.
https://doi.org/10.1182/blood-2023-179733
Published: 2023
Journal Articles

Complement Activation May Trigger the Onset of Thrombotic Thrombocytopenic Purpura in Patients with Severe ADAMTS13 Deficiency

Free
Xiao-Hui Hu, MD, PhD, Jialing Bao, PhD, Yoshiyasu Ueda, MD, PhD, Takashi Miwa, PhD, Wenchao Song, PhD, X. Long Zheng, MD, PhD
Journal: Blood
Blood (2014) 124 (21): 600.
https://doi.org/10.1182/blood.V124.21.600.600
Published: 2014